EF1a-dCasRx-RBM25
(Plasmid
#221001)
-
PurposeTransient expression of dCasRx-RBM25. EF1a promoter.
-
Depositing Labs
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 221001 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepXR002 (Addgene #109050)
-
Vector typeMammalian Expression, CRISPR
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert
-
Gene/Insert namedCasRx-RBM25
-
Alt nameHuman RBM25 fused C-terminal of dCasRx
-
SpeciesH. sapiens (human)
- Promoter EF1a
-
Tags
/ Fusion Proteins
- NLS (N terminal on insert)
- NLS-HA (C terminal on insert)
Cloning Information
- Cloning method Gibson Cloning
Resource Information
-
A portion of this plasmid was derived from a plasmid made byBackbone and dCasRx coding sequence from Konermann et al., 2018 (Addgene #109050)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Co-transfect with gRNA vector at a 1:1 ratio. Highly efficient transfection is required for optimal transient splicing modulation. For hard to transfect cells we recommend either sorting for BFP expression (on the gRNA vector), or using the stable expression system. For additional details, please see our paper.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
EF1a-dCasRx-RBM25 was a gift from Benjamin Blencowe & Mikko Taipale (Addgene plasmid # 221001 ; http://n2t.net/addgene:221001 ; RRID:Addgene_221001) -
For your References section:
Efficient, specific, and combinatorial control of endogenous exon splicing with dCasRx-RBM25. Li JD, Taipale M, Blencowe BJ. Mol Cell. 2024 Jul 11;84(13):2573-2589.e5. doi: 10.1016/j.molcel.2024.05.028. Epub 2024 Jun 24. 10.1016/j.molcel.2024.05.028 PubMed 38917795